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Abstract
In neuromodulation, by delivering a form of stimulus to neural tissue the response of 
an associated neural circuit may be changed, enhanced or inhibited (i.e., modulated) as 
desired. This powerful technique may be used to treat various medical conditions as 
outlined in this chapter. After a brief introduction to the human nervous system, key 
example applications of electrical neuromodulation such as cardiac pacemakers, devices 
for pain relief, deep brain stimulation, cochlear implant and visual prosthesis and their 
respective methods of deployment are discussed. Furthermore, key features of wear-
able neuromodulators with reference to some existing devices are briefly reviewed. This 
chapter is concluded by a case study on design and development of a wearable device 
with non-invasive electrodes for treating lower urinary tract dysfunctions after spinal 
cord injury.
Keywords: lower urinary tract, electrical stimulation, nervous system, 
neuromodulation, spinal cord injury, TENS, transcutaneous stimulation
1. Introduction
In neuromodulation by applying a form of stimulus to neural tissue, the response of the under-
lying neural circuits is modulated and a response is evoked. In this chapter, we solely focus 
on electrical stimulation of neural tissue. Neuromodulation is used to suppress pain, assist 
locomotion, treat various conditions and rehabilitate patients. Current neuromodulators are 
primarily used for medical purposes. Neuromodulators may be classified as invasive, where a 
form of surgical operation is required to implement the technique, or non-invasive, where sur-
face electrodes are used. Due to the risks associated with surgery and high cost, non-invasive 
solutions are more desirable. Both classes of neuromodulators may be controlled by the user 
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or be completely autonomous and this depends on the application. Most of them are portable 
and may be on the person while they go about their daily life. Invasive neuromodulators may 
not be removed when desired. However, if they are composed of external and implanted units, 
the external part may be detached from the patient if needed. While connectivity can be read-
ily incorporated in such devices, this is not at this stage a fundamental part of such solutions.
After an introduction to human nervous system, fundamentals of neuromodulation are 
described in this chapter. Key examples of neuromodulation devices are briefly discussed, 
followed by a note on wearable neuromodulators. This chapter is concluded by a discussion 
on the design and development of a wearable neuromodulator to treat lower urinary tract 
(LUT) dysfunctions after spinal cord injury (SCI).
2. Human nervous system
This section is a brief and general introduction to human nervous system, aiming to assist 
readers in understanding what follows in the chapter.
2.1. Central and peripheral systems
The human nervous system may be divided into central and peripheral systems. The cen-
tral nervous system (CNS) comprises the brain and the spinal cord and the peripheral ner-
vous system (PNS) mainly includes the nerves that connect the periphery of the body to the 
CNS. The brain comprises the cerebral hemispheres, diencephalon, cerebellum, and the brain-
stem. The spinal cord connects lower parts of the body to the brain and can be divided into 
four sections, each of which has various segments from top to bottom: cervical (C1–C8), tho-
racic (T1–T12), lumbar (L1–L5), and sacral (S1–S5) [1].
The PNS comprises the spinal nerves, originating from the spinal cord, and most of the cranial 
nerves, originating from the brain, above the spinal cord. The peripheral nerves originating 
from a specific segment of the spinal cord (C-S) generally mediate a specific functionality. The 
PNS may be subdivided into the autonomic nervous system and somatic nervous system. 
Generally, the former oversees the involuntary control and the latter provides the voluntary 
control. The autonomic nervous system may be further divided into sympathetic and para-
sympathetic nervous systems. The sympathetic nervous system may be perceived to oversee 
the fight-or-flight response while the parasympathetic nervous system is responsible for the 
rest-and-digest functions.
2.2. Key elements
There are two main classes of cells in the nervous system: nerve cells (neurons) and glial cells 
(glia). Generally, the former are the ones involved in neural signaling and the latter function 
as support cells. Typically, a neuron may consist of four distinct regions: a soma, dendrites, 
an axon, and presynaptic terminals [2]. The main function of neurons is to convey the neural 
signal (i.e., action potential (AP)).
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Soma houses cell genes and proteins are synthesized in it. A soma may give rise to two types 
of projections, also referred to as processes. There may be one long axon, also referred to 
as the nerve fiber, which acts as the main conducting unit of the neural signal (i.e., AP) to 
other neurons. Other projections, which are generally shorter and branch-like, are dendrites. 
Dendrites may be thought of as the main neural signal receiving ports in a neuron. Near the 
end, an axon divides into these branches which communicate with other neurons through 
the presynaptic terminals. The point of communication between a neuron and other neurons 
is called a synapse. The cell transmitting the signal is called a presynaptic cell and the one 
receiving it is called the postsynaptic cell. Presynaptic terminals land on the soma and/or the 
dendrites of a subsequent cell. Depending on the functions of the cells their morphology may 
vary [1, 2].
Glial cells surround neurons and have various functionalities including acting as the general 
and structural support for neurons. Schwann cells and oligodendrocytes insulate axons in the 
PNS and CNS, respectively [3]. Schwann cells form the myelin sheath which essentially acts 
as insulation around a nerve fiber, referred to as myelination. Fibers may be myelinated or 
unmyelinated and, consequently, they show different characteristics. In a myelinated fiber, 
large segments along its length are wrapped by layers of myelin while only small segments 
between the wrapped segments are left exposed at regular intervals. The exposed segments 
are referred to as the nodes of Ranvier. There are other types of glial cells that are thought to 
bring nutrients to cells, provide the blood-brain barrier and help maintain the right ion con-
centration. They also absorb neurotransmitters and some are only recruited during infection, 
injury and seizure [1].
In PNS, generally, there are two roots originating from the spinal cord. The dorsal root con-
veys the sensory information while the ventral root conveys the motor signaling. The dorsal 
root then enters the dorsal root ganglion, a local accumulation of cell bodies and supporting 
cells. Peripheral axons may be bundled into what is called nerves. The nerves from the dorsal 
and ventral roots merge to form the spinal nerve. In CNS, cell bodies may be arranged in two 
ways. Nuclei are the local accumulations of neurons with similar connections and function-
alities, such as the collections found in the cerebrum, brainstem, and spinal cord. The second 
arrangements are cortices which are sheet-like arrays of cells such as those found in the cere-
bral hemispheres and cerebellum. The axons in the CNS are gathered into tracts, analogous 
to nerves in the PNS. Tracts that cross the mid-line of the brain and spinal cord are referred 
to as commissures. The term gray matter identifies any accumulation of cell bodies and neu-
ropils (synaptically dense regions of dendrites, synaptic terminals, and glial cell processes) in 
the brain and spinal cord (e.g., nuclei or cortices) while white matter is essentially tracts and 
commissures.
2.3. Afferent and efferent neurons
In terms of functionality or the direction of conveying the neural signal, neurons are classified 
into three major groups: afferents, efferents and interneurons. Afferents carry information 
from the periphery of the body to the CNS. These neurons are very often interchangeably 
referred to as sensory neurons although not all afferent communications may lead to a form 
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of sensation [1]. Efferents or the motor neurons carry the neural signal and commands from 
the CNS to muscles and glands. Interneurons, which are neither sensory nor motor, constitute 
the largest group of neurons [1]. Interneurons convey APs over long or short distances from 
a neuron to the other.
2.4. Neural circuits, receptors and transmitters
Neurons are organized to form neural circuits and reflexes which may, for instance, process 
the sensory information and elicit motor responses. A typical circuit on the afferent end may 
be terminated by sensory receptors. These are nerve endings which transduce specific stimu-
lus energies into the corresponding receptor potentials. Receptors are specialized in terms of 
the energy they transduce which may be electromagnetic, mechanical, thermal or chemical 
[4]. A complex sensation such as pain may recruit different receptors. The receptor potential 
then travels along the attached afferent fiber with a specific AP firing pattern. The attached 
afferents may covey a specific mode of sensation as well. The cell bodies of these afferents 
may be in the corresponding ganglia. The central axon of the mentioned cell might enter 
through the dorsal horn of the gray matter of the spinal cord and synapse with central neu-
rons. Namely, it may synapse with interneurons or motoneurons in the spinal cord.
The basic forms of the synaptic transmission between neurons are electrical and chemical 
while most of the transmissions are chemical [4]. While at an electrical synapse a low resis-
tance electrical path exists between the two associated cells, at chemical synapses neurons are 
separated completely by a small space called the synaptic cleft. The entities that essentially 
pass the neural signal from a presynaptic cell to a postsynaptic cell are called neurotransmit-
ters. The arrival of an AP at the presynaptic side of a synapse leads to the release of chemical 
neurotransmitters which then diffuse across the cleft and interact with the receptors of the 
postsynaptic side. This interaction leads to either excitation or inhibition. The former leads 
to the suppression of the AP generation while the latter leads to the generation of APs. The 
type of the resulting action, primarily, depends on the type of the transmitter and receptor 
involved. Also, the synaptic input may add up from various presynaptic cells.
The sensory information may be conveyed through the white matter of the spinal cord to dif-
ferent regions in the brain for further processing. In which case, the response of the brain may 
be conveyed back to the target cells through different regions of the white matter of the spinal 
cord. A spinal reflex on its own may result in a motor activity without any modulatory input 
from the brain [1]. Through the ventral horn of the gray matter, efferent fibers leave and land 
on target muscles or organs. At a neuromuscular junction, neurotransmitters are released and 
the corresponding contraction or relaxation effects are mediated.
2.5. Action potential
Having presented an overview of different elements and aspects of the human nervous sys-
tem, we now discuss the AP as the most fundamental phenomenon in the nervous system fur-
ther. An AP is a rapid (~1 ms) variation (~100 mV) of the transmembrane potential [1, 3]. APs 
are naturally triggered in the initial segment of the attachment of an axon to its corresponding 
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soma and travel down the axon at velocities ranging from about 1-120 m/s depending on the 
fiber type [4]. Different activities are mediated via this signal throughout the nervous system 
by the neural circuits mentioned before. The actual command or information is not perceived 
by the variation of the signal (i.e., AP) but different effects are mediated through the paths 
APs travel and their firing pattern.
Generally, there are three main temporal phases in an AP. The resting potential, the trans-
membrane voltage from inside to outside in the absence of any stimuli, is a negative value. 
Upon an increase in the transmembrane potential beyond a threshold, it rapidly increases 
to a specific positive value. This phase is called the depolarization period. The AP genera-
tion is an all-or-none process, meaning that any rise smaller than the said threshold does not 
yield such a response. The depolarization phase is followed by the subsequent reduction in 
the transmembrane potential which is called the repolarization phase. The transmembrane 
potential reduces even below its initial resting potential for a period which is referred to as 
the hyperpolarization phase. There exists the absolute refractory period in which no action 
potential may be triggered in the segment of the membrane under question. This is followed 
by the relative refractory period during which period a stronger than normal stimulus may 
produce a new AP [5].
The generation and propagation of APs are mediated by voltage-gated ion channels in the 
membrane and the subsequent influx and outflow of ions. These channels are ion specific, 
meaning that when they are open they are only permeable to a specific ion. Also, the state that 
these channels are at depends on the transmembrane potential. Supposing that two media 
are separated by an ion specific channel and the density of that ion is different in the two 
media, ion flows against the concentration gradient. It is noted that ions do not exist in isola-
tion, meaning that a positive ion is paired with a negative one. Thus, as ions that the barrier 
is permeable to diffuse, assuming a positive ion is diffusing, an electric field is built up in the 
direction of the concentration gradient. The opposing forces of the concentration-dependent 
diffusion and electric field reach an equilibrium, at which stage there is no net ion flow. By 
equating these opposing forces, the transmembrane electric potential at which the equilib-
rium is reached can be calculated. This is referred to as Nernst voltage. Nernst voltage is 
measured from intracellular to the extracellular space. Thus, a higher concentration of a posi-
tive ion outside the cell results in a positive Nernst voltage for that ion. Where several ion 
species are present, the transmembrane potential can then be calculated using the Goldman-
Hodgkin-Katz formulation. Building on the Nernst equation, if the membrane becomes more 
permeable to a specific species, the equilibrium potential tends to the Nernst potential of that 
species. The resting potential is not a case of equilibrium but that of the steady state.
The permeability of channels is governed by the voltage-gated channels mentioned before. 
The pioneering work of Hodgkin and Huxley (HH) [6] laid the foundation for the existing 
systematic understanding of the channel mechanisms. By setting the transmembrane voltage 
to a predetermined value and measure the transmembrane current for the said voltage in the 
giant axon of loligo, HH formed a set of curves of the conductivity of the membrane to potas-
sium and sodium versus time for various depolarization voltages. Apart from the overall 
time trace, they noticed that as the clamp voltage increases, the rate at which the conductance 
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varies increases too. They decided to use first order kinetics (multiple processes if necessary) 
to fit the experimental data and consider activation and inactivation variables to explain the 
cessation of conductivity following its initial rise. Although HH developed a merely empiri-
cal formulation for the observations but the overall macroscopic system of equations they 
defined is compatible with the microscopic understanding which exists today [1]. The chan-
nels have gates that depending on the voltage across them the rate at which they open or close 
varies. For a channel to conduct, all its gates should be open. The concentration of the sodium 
ions in the extracellular space is much more than those in the intracellular space while that 
of potassium ions is the other way around. Therefore, the opening of the sodium channels 
results in a rise of the transmembrane potential while the opening of the potassium channels 
results in its reduction.
Assuming only sodium and potassium ions are involved, a full cycle of the AP generation is 
described as follows. The inputs in an axon hillock raise the transmembrane potential beyond 
a threshold at which point the permeability of the membrane to sodium and potassium ions 
increases. The conductivity of sodium channels increases faster than those of potassium ions. 
Thus, the influx of sodium ions brings the transmembrane potential closer to the equilibrium 
potential of sodium ions. At the higher transmembrane potentials, the conductivity of the 
membrane to potassium ions increases while sodium channels start to inactivate, reducing 
the membrane permeability to sodium ions. This results in repolarization of the membrane. 
The inactivation of sodium channels and the prolonged permeability of the membrane to 
potassium ions result in the lowering of the membrane potential below the resting potential 
and closer to the equilibrium potential of potassium ions. Several more channel types may be 
involved in different species but the overall process is generally similar.
When an AP is generated, it automatically induces the generation of other APs in its vicinity 
[1, 4]. Considering unmyelinated fibers, the extracellular and intracellular current flows along 
the fiber induce an increase in the transmembrane potential near the depolarized segment. 
When the AP is induced in a segment of the fiber, the preceding segment is in the hyperpo-
larization phase, thus, the AP travels in a specific direction. In the case of a myelinated fiber, 
as the current loops are relatively weak where the myelin insulation is present, the loops are 
at their highest intensity from a node to the other, resulting in the AP essentially hoping from 
a node to the other, rendering the transmission much faster. Apart from myelination, fiber 
diameter also affects the conduction velocity. Larger fiber diameters generally have higher 
conduction velocities. Depending on the size and conduction velocity of fibers, Erlanger’s 
(A𝛼, A𝛽, Aδ, B and C) and Lloyd’s (I, II, III and IV) systems have been proposed for a clas-
sification of fibers [1, 4].
3. Fundamentals of neuromodulation
Neuromodulation has two components. The first component involves the delivery of the stim-
ulus current to produce APs in a target neural tissue and the second one is the way this leads 
to a response. If a nerve is pierced via an electrode and the transmembrane voltage is forced 
more positive, then APs may be generated. Often, fibers are stimulated by merely perturbing 
Wearable Technologies76
the extracellular potential. Assuming a cathode–anode pair is placed along a fiber at a distance 
away from it, the extracellular space near the cathode may become more negative and this 
forces transmembrane voltage there more positive. This may lead to the generation of a propa-
gating AP in that position. This yields a very simplistic view of electrical stimulation. The actual 
process is far more complex and requires an understanding of HH type models of the fiber.
In an electrical conductor, charge carriers are primarily electrons while in the tissue they are 
ions. Thus, electrodes may be thought of as the interface between these two media. It is, there-
fore, understandable that the processes involved are electrochemical and reduction and oxi-
dation processes may happen at the electrodes which are not infinitely fast and unimpeded. 
Furthermore, due to the adsorption of charges and redux processes, the interface impedes 
the flow of current. The contact impedance due to these plays an important role in electrode 
material selection and design. Enough charge should be pumped into the medium to suffi-
ciently perturb the extracellular potential. When applied as a pulse, the strength and duration 
of the pulse dictate how much charge is delivered. This leads to the formation of the strength-
duration curves that identify a balance between the amplitude and the duration of stimulus 
pulses. The electrode design, its relative position with respect to the nerve and characteristics 
of the surrounding tissue, among other features, play a significant role in defining the stimu-
lus pulse design. Moreover, there are safety considerations when charge is injected into the 
tissue. To understand the dynamics and safety considerations when injection stimulus cur-
rent through electrodes the following description should be considered.
As an electrode is put into contact with an electrolyte (tissue) a potential develops which is 
primarily governed by the Nernst formulation and is referred to as the equilibrium potential 
of the electrode. As the current is injected through the electrode, the potential of the electrode 
rises above the equilibrium, at which time the potential dependent reversible and irreversible 
Faradaic processes may occur. Such reactions are dependent on the fastness of the kinetics 
of the said reactions and the speed of the mass transport [7]. A kinetically fast process with 
respect to the mass transport requires a small over-potential, defined as the variation of the 
electrode potential from its equilibrium potential, to lead to a significant amount of current 
flowing. As the reactants, consequently, do not move away from the surface, applying current 
in the reversed direction may force the reactions to be reversed (i.e., biphasic charge balanced 
stimulation). Kinetically slower reactions are limited by the mass transport. Thus, the reactants 
move away from the surface as the reactions occur at higher over-potentials [7]. These reactions 
are referred to as the irreversible Faradaic processes while those involving kinetically fast pro-
cesses are reversible. One of these irreversible processes is the electrolysis of water. This may 
happen above and below a certain positive and negative potential, respectively, for a given 
electrode material. The range of the potential below these limits (i.e., safe limits) is referred 
to as the water window. The electrolysis of water results in pH changes and gas formation 
which may lead to tissue and electrode damage. It is noted that electrode material forms a very 
important feature of the design. The safe limits of the charge injection and the general electrical 
properties of the electrode should be considered. Under most neural stimulation conditions, 
the Faradaic processes dominate [8], noting the existence of non-Faradaic currents at the elec-
trode interface as well. Thus, it is important to ensure a given material can safely deliver the 
required charge. Electrodes may be implanted or surface electrodes may be used. The former 
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is invasive but the delivery of charge is direct while the latter may be non-invasive but the cur-
rent have a large spread. Unfortunately, it has been shown that risk versus expected benefit 
has a linear relationship, the higher the risk the more substantial reported benefits, for different 
methods of stimulation [9]. This may be attributed to efficacy and selectivity. While non-inva-
sive electrodes are simply conductive patches attached to the surface of the body, minimally 
invasive electrodes may be designed as needles piercing the skin to deliver the stimulus cur-
rent. General classes of invasive electrodes for PNS in increasing order of invasiveness include 
extraneural, interfascicular, intrafascicular and those relying on the regeneration of the neural 
tissue in them. Examples of these electrodes are cuff electrodes, flat interface nerve electrodes 
(FINESs), longitudinal intrafascicular electrodes (LIFEs), transverse intrafascicular electrodes 
(TIMEs) and various multi-channel electrodes [10]. For the CNS, the general classification of 
electrodes is superficial/distal and those for deeper structures.
The second component of neuromodulation is the way the stimulus current leads to a desired 
response from the associated neural circuits. This may be a simple motor response by stimu-
lating the very same motor fibers or may involve much more complex circuits involving PNS 
and CNS. Thus, in designing the stimulus signal one should also consider the appropriate 
features that lead to the desired response. This may include, but is not limited to, stimulus 
waveform and frequency.
4. Example applications of neuromodulation
A very well-known example of neuromodulators is the cardiac pacemaker. Electrodes are 
inserted transvenously and placed at the targeted chamber of the heart. The pulse generator 
is placed in a subcutaneous or submuscular position. Electrical stimulus may be applied in a 
unipolar or bipolar fashion and the process can be synchronized with hearts pace [11].
One of the applications of neuromodulation is for chronic pain management. Transcutaneous 
electrical neural stimulation (TENS) owing to its simple delivery method has been investigated 
for many years. Various waveforms and frequencies have been used. The placement of elec-
trodes may be directly over the painful area, its peripheral neural supply, the dermatome of 
the associated spinal roots and known trigger points. It is thought that the resulting analgesia is 
due to the activation of central inhibitory mechanisms. For instance, stimulation of Aβ afferent 
fibers are thought to lead to inhibition of nociceptive C and Aδ afferent fibers in some cases. 
Examples of devices developed based on TENS concepts include NEMOS (Cerbomed GmbH, 
Erlanger, Germany), a portable device that targets the auricular branch of the vagus nerve 
via electrodes placed on the concha of the outer ear, Cefaly (CEFALY-Technology, Seraing, 
Belgium), a wearable device for supraorbital stimulation by a bipolar electrode patch on the 
forehead and gammaCore (electroCore LLC, NJ, USA), a handheld noninvasive vagal nerve 
stimulator, all for the treatment and management of migraine. Spinal cord stimulation using 
implanted electrodes [12], occipital nerve stimulation using implantable electrodes [13], tran-
scranial magnetic stimulation [14] and transcranial direct current stimulation [15] have also 
been used to treat various neuropathic pain patients.
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Deep brain stimulation (DBS) is one of the key applications of neuromodulation that has 
found applications in treating Parkinson’s disease [16], essential tremor [17], dystonia [18], 
Tourette syndrome [19], chronic pain [20], epilepsy [21], Huntington’s disease [22] and even 
mental disorders [23] with different sites of stimulation. A linear electrode array is implanted 
deep in the brain. In many of the above cases the exact mechanisms that lead to desirable 
outcomes using DBS are not known due to the complexity of neural circuits in the brain. 
However, its efficacy has promoted its use and further research.
A very successful example of neuromodulators is the cochlear implant [24] in which the audi-
tory nerve is stimulated via electrodes placed on a flexible platform that is placed in a layer of 
the cochlea (basilar membrane). Sound is recorded externally and upon processing the stimu-
lation paradigm is inductively transmitted to the electrodes. Sound as a mechanical wave 
hits the tympanic membrane (i.e., eardrum). Ossicles, three bones connected to the tympanic 
membrane, convey this motion to the cochlea which is filled by fluid. At a layer of the cochlea 
there exists the basilar membrane which is stiff and narrow near the ossicles and wide and 
flexible on the other end. Due to this structure, the thinner segments resonate with higher fre-
quencies. The hair cells on the basilar membrane then translate this to a neural signal which 
is conveyed through the auditory nerve. The basilar membrane may be appropriately stimu-
lated to induce hearing perception.
Visual prosthesis is another example of using neuromodulation to restore function. One of the 
most common forms of blindness in the developed world is neural blindness. This is generally 
due to the loss of photoreceptors. In many cases part of the neural circuits between the recep-
tors and the brain survive and this may be harvested to restore vision. Light passes through 
the cornea, pupil and lens and is shone on the retina. Retina is covered by photoreceptors (rod 
cells, more populous and specialized for dim light and cone cells, for bright light and colors) 
that transduce light to a neural signal which goes through the visual pathway to be perceived 
in the visual cortex of the brain. Electrical stimulation may be delivered in various places [25]. 
The stimulation may be delivered via epiretinal [26], subretinal [27] or suprachoroidal [28] 
electrode arrays. Stimulation may be delivered by deriving the appropriate pattern via an 
external sensor like camera and transmitted via an inductive link to the array or the photo 
sensors may be integrated with the electrodes. Stimulus current may also be delivered to optic 
nerve [29], lateral geniculate nucleus [30] or even the visual cortex itself [31].
Electrical stimulation may be applied to restore or rehabilitate motor function. In this case 
it is referred to as functional electrical stimulation (FES). While not in all cases of FES a neu-
ral reflex may be modulated, due to its significance we briefly discuss it here. FES may be 
delivered via implanted electrodes [32], percutaneously [33] or transcutaneous [34] in various 
places. FES have been used in a variety of applications such as improving activity after stroke 
[35], chronic heart failure [36] or control and rehabilitation of extremities following spinal 
cord injury [37] or other forms of neural disease.
Neuromodulation may be used to treat various lower urinary tract dysfunctions that arise 
upon spinal cord injury. A more elaborate description of such interventions is presented as a 
case study in designing a wearable neuromodulator later in this chapter.
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5. Common features of wearable neuromodulators
The introduction to key underpinning concepts surrounding neuromodulation and the key 
applications presented in this chapter reveal the great potential of the method in improving 
the quality of life for patients in a variety of patient groups. However, the concept of wearable 
neuromodulators in terms of their defining features should be further discussed.
In most devices currently advertised as wearable neuromodulators such as Senza system (Nevro 
Corp., CA, USA) for spinal cord stimulation for pain relief, a range of products from Bioness 
(Bioness Inc., CA, USA) for improved mobility, Stimwave (Stimwave Technologies Inc., FL, 
USA) for pain relief, Bionode (Bionode LLC, IN, USA) for glaucoma, Reliefband (Reliefband 
Technologies LLC, PA, USA) for nausea treatment, various products from Bioelectronics 
(BioElectronics Corporation, MD, USA) for pain management, Quell (NeuroMetrix Inc., MA, 
USA) for pain relief and Cefaly (CEFALY-Technology, Seraing, Belgium) for migraine, porta-
bility, in a sense that they do not impede the normal life of the user, appears to be the primary 
common factor. The other common feature of these technologies is that they have a control-
lable interface with the user, even if this is simply for turning the device on or off. While most 
of the wearable neuromodulators are non-invasive but this is not necessarily a common fea-
ture among all the neuromodulators referred to as wearable. For devices whose electrodes are 
implanted higher efficacies are expected but various challenges including the risk of surgery, 
possible electrode migration and power delivery to internal unit should be tackled.
6. A case study
This section presents a brief case study on designing a wearable neuromodulator for treating 
LUT dysfunctions after SCI.
6.1. Functions of the LUT
The main functions of the LUT are to store and periodically void urine. These functions are 
performed by the main functional units of the LUT. These functional units include the uri-
nary bladder and an outlet consisting of the bladder neck and urethra. The urinary bladder 
is engulfed in a smooth muscle called the detrusor while the urethra, the projecting tube 
from the bladder, is composed of smooth and striated muscles. During the storage phase, the 
urinary bladder relaxes while its outlet contracts and during the voiding phase the bladder 
contracts while the outlet relaxes. These synergic and reciprocal activities of the functional 
units are controlled by complex neural circuits [38].
6.2. Neural control of the LUT
Current understanding of neural control of the LUT is based on studies on various species. 
This section aims to draw a simple picture of the way the circuits are thought to be formed. 
The associated neural circuits are primarily controlled in the brain, spinal cord, and peripheral 
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ganglia. The intricacy of the neural circuits is partly due to LUT functions being under the 
somatic as well as autonomic control and partly due to the required switching action between 
the reciprocal activities. Four types of neurons are thought to be involved in the neural con-
trol of the LUT functions: the primary afferent neurons, spinal efferent neurons, spinal inter-
neurons and neurons in the brain. These neurons activate or modulate the reflexes [38].
The autonomic nervous system controls the LUT through the sympathetic nervous system, 
primarily via the hypogastric nerve, and parasympathetic nervous system, primarily via the 
pelvic nerve. The somatic control of the LUT is mediated by the pudendal nerve. It is gener-
ally thought that the activation of the sympathetic nervous system is responsible for main-
taining continence while the activation of the parasympathetic system facilitates voiding [39]. 
Various excitatory and inhibitory neurotransmitters and the associated receptors are involved 
in the healthy function of the LUT.
Intrinsic properties of the detrusor, leading to low and constant intravesical pressure during 
the storage and filling, inhibition of the parasympathetic outflow to detrusor, activation of 
sympathetic efferents to the outlet and pudendal efferent activities are some of the features 
that might contribute to continence based on studies on various species. Spinal and supra-
spinal reflexes activated by afferent activities are thought to mediate these. Upon voluntary 
decision for voiding in healthy adults, the sympathetic and somatic outflows are inhibited 
and the parasympathetic efferents are activated to facilitate voiding by an initial relaxation of 
the outlet and the subsequent contraction of the reservoir [38, 39].
6.3. LUT after SCI
The spinal cord is the major pathway through which efferent and afferent command and 
information travel between the brain and the body. The spinal cord contains longitudinally 
oriented spinal tracts (white matter) surrounding its central areas (gray matter) where most 
of the spinal nerve cell bodies are located. The gray matter is organized into segments that 
comprise sensory and motor neurons. As briefly discussed earlier in the chapter, every seg-
ment of the spinal cord is generally in charge of controlling a specific part of the body and 
functionality. Thus, damage to a specific segment of the spinal cord may result in the loss of 
control in the corresponding part of the body.
SCI may be divided into two major groups. Tetraplegia is the impairment or loss of motor 
and/or sensory functions in the cervical segments of the spinal cord due to the damage of the 
nervous system within the spinal canal. Paraplegia is the impairment or loss of motor and/or 
sensory functions in the thoracic, lumbar or sacral segments of the spinal cord. Neurological 
level of injury refers to the most caudal segment of the spinal cord with normal sensory and 
anti-gravity motor function on both sides of the body provided that there is an intact sensory 
and motor function rostral to that position [40]. SCI may also be divided into incomplete 
and complete. In an incomplete injury there is a preservation of some sensory and/or motor 
function below the neurological level that includes the lowest sacral segments. In contract, 
a complete injury refers to the situation when there is an absence of any sensory and motor 
function below lesion [40].
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Given the intricate neural circuits involved and the switching-like somatic control of the LUT 
functions, it comes as no surprise that after SCI both functions of the LUT may be significantly 
disrupted. Depending on the location of the lesion and its completeness the degree of LUT 
dysfunctions and their nature may vary. After SCI above a lumbo-sacral level, understand-
ably, the input from higher orders in the brain and, consequently, the voluntary control of the 
LUT may be disrupted. After a period, new sacral spinal reflexes develop. It is thought that 
these reflexes are mediated by C fibers which are generally thought to be mechanically silent 
in healthy individuals but become sensitive to low volume bladder activities after injury. 
Thus, contractions occur during the filling phase of the bladder [41]. Major conditions appear-
ing after SCI include the neurogenic detrusor over activity (NDO) and detrusor sphincter dys-
synergia (DSD). The NDO involves the existence of bladder contractions at low volumes and 
the DSD is the condition in which the reciprocal activities of the bladder and the outlet are not 
maintained, hence bladder contractions are mirrored with contractions in the urethra [41]. If 
untreated, these conditions may have severe consequences for the patient.
6.4. Existing solutions
Solutions to the NDO and DSD may be divided as pharmaceutical, mechanical and surgical. 
Mechanical devices may be subdivided into passive and active devices. The latter are primar-
ily the kind of devices used for the neuro-muscular stimulation. In the case of the NDO, typi-
cally, the first devised treatment involves anticholinergic drugs [42]. High doses of prescribed 
anticholinergic drugs may lead to troublesome side effects including dry mouth, blurred 
vision, constipation and cognitive impairment [41]. If such drugs do not yield the desired 
response, more intrusive interventions, including surgical operations, may be devised. 
Bladder augmentation, an operation in which a section of the intestine is used to increase the 
bladder volume, can be used to partially suppress the NDO [43]. For the DSD, catheterization, 
pharmacologic agents, injection of botulinum A toxin, urethral stents, artificial sphincters, 
sphincterotomy, which is a complex procedure in which urethra is cut into several times to 
incapacitate it, are some of the key options [42, 43]. Intermittent catheterization, developed in 
the twentieth century, is the predominant solution used in tandem with drugs for NDO and 
voiding. The major issue with catheterization is that it is the foremost cause of re-hospitaliza-
tion due to infection in the people with SCI [42, 43].
The application of electrical stimulus current to treat LUT dysfunctions has been extensively 
explored at various sites in the body. The stimulus current may target the excitable tissue of 
the bladder directly in the form of an intravesical stimulation or bladder wall stimulation to 
facilitate voiding. Such solutions may be used in patients with damaged lower motor neu-
rons in which cases the neural stimulation is not possible [43]. As an example for stimulating 
other sites, Finetech-Brindley system (Finetech Medical Ltd., Welwyn Garden City, UK) is a 
solution for sacral anterior root stimulation [44] for voiding. Efferent fibers, supplying both 
the detrusor and urethra, are stimulated by implanting electrodes intradurally or extradu-
rally, resulting in the contraction of both. However, when the stimulus is removed the urethra 
relaxes much faster than the detrusor and this leads to voiding. This voiding would be non-
physiological but yields high voiding efficiencies. For the solution to be effective, posterior 
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rhizotomy has been performed in subjects to increase the bladder capacity and compliance 
by suppressing hyperreflexive contractions of the bladder. Unfortunately, this irreversibly 
eliminates the reflex erection, reflex micturition and any remaining pelvic sensation. To treat 
hyperreflexive contractions of the bladder, Interstim system (Medtronic, MN, USA) for sacral 
nerve neuromodulation has been implemented by delivering a low frequency and low ampli-
tude stimulus via an electrode set, usually placed near the S3 spinal nerve. The effect has been 
attributed to the inhibitory modulatory effect of somatic afferents on motor fibers to the blad-
der. Other examples are tibial nerve stimulation to suppress the NDO and the pelvic nerve 
stimulation to facilitate voiding.
Efferent and afferent pathways of pudendal nerve innervate various pelvic structures includ-
ing the external anal sphincter, external urethral sphincter, genitalia and urethra. The nerve 
is paired and its lateral branches originate from both sides of the sacrum. Through the lower 
part of the left and right sciatic foramen, the nerve’s lateral branches enter the gluteal region. 
Turning around the sacrospinous ligament near its attachment to the ischial spine, the puden-
dal nerve re-enters the perineum via the lesser sciatic foramen. Running across the distal edge 
of the ischioanal fossa, the nerve gives rise to its terminal branches in an area referred to as the 
Alcock’s canal [45, 46]. The branching pattern and the course of the nerve have been shown to 
be highly variable across different individuals [47]. Pudendal nerve stimulation for LUT dys-
function in SCI patients at various positions along the course of the nerve, through different 
terminal branches and using various stimulation parameters has been the topic of research 
by many workers [48–55]. A key point is that depending on the position and frequency of 
the stimulus current pulses, voiding or inhibition effects may be achieved. Also, the pattern 
of the stimulus pulses may induce different responses. These may be attributed to pudendal 
afferents being involved in both voiding and storage reflexes.
6.5. A wearable device
The course of the pudendal nerve provides the opportunity of its trans-rectal stimulation 
using an ano-rectally worn probe with surface electrodes. If electrodes are positioned near 
the ano-rectal junction, it is likely to expose the compound pudendal nerve to the stimulus 
current. This way, it may be possible to devise a wearable solution to treat various bladder 
dysfunctions after SCI. Another interesting feature of this solution when used to improve 
continence is that the efficacy and viability of the solution may be improved using conditional 
stimulation in SCI [56]. The majority of cases of the NDO after SCI are accompanied by the 
DSD [41]. Thus, any contraction in the bladder is mirrored by contractions in the external 
urethral sphincter. It has been shown that electromyogram (EMG) signal recorded from the 
external anal sphincter may be used as a surrogate for that of the external urethral sphincter 
which demonstrates the onset of the hyper-reflexive contractions of the bladder [57, 58]. Due 
to the closeness of these sites the recording and stimulation may be performed by surface 
electrodes mounted on the same probe.
Intra-anal and vaginal stimulation is primarily used for an acute delivery of the stimulus 
current to pelvic structures and for therapeutic purposes. An early attempt to stimulate the 
Wearable Neuromodulators
http://dx.doi.org/10.5772/intechopen.76673
83
pudendal nerve trans-rectally reported current levels were as high as 100 mA to yield a vis-
ible response [59] which is in agreement with more recent results [57]. This might impede the 
chronic use of the solution. Knight et al. [57] based on a patented technology [60] for condi-
tional trans-rectal neuromodulation of the pudendal nerve and inspired by an earlier study 
by Brindley et al. [61] in a study on 6 SCI patients suffering from the NDO and DSD showed 
that by the conditional neuromodulation of the pudendal nerve, hyper-reflexive contractions 
of the bladder were suppressed. The control signal was set to be the EMG signal from external 
anal sphincter. They designed the probe more suited to chronic use by considering the anat-
omy of the anal canal and making the probe from silicone rubber with stainless steel surface 
electrodes. However, still high levels of required stimulus current were reported. Figure 1  
shows the probe used in experiments.
The study presented by Knights et al. [57] similar to previous studies was not tested for pro-
longed use. For chronic use, high levels of the stimulus current may result in the habituation 
of the nerve even under the conditional stimulation. For sensate individuals, such levels of the 
stimulus current may be beyond the pain threshold and at high levels of the stimulus current 
the targeting accuracy required may be lost. Any structure in the vicinity may also be stimu-
lated, resulting in unforeseen responses. Also, high levels of the stimulus current increase 
the possibility of electrode or tissue damage. Therefore, the design of electrodes should be 
optimized to minimize the stimulus current. Even if the current is minimized, however, the 
challenge is that the course of the nerve is highly variable between different individuals as 
discussed earlier in this chapter. Furthermore, the pelvic structures move depending on the 
posture of the individual. This adds to the variations of the course of the nerve with respect 
to the device. Using computational model we designed [62] an electrode setting that based 
on modeling results may be capable of activating the pudendal nerve at much lower thresh-
olds considering all the factors described above. Such models implement what is referred to 
as hybrid models in the literature. The electrical potential field generated by the stimulation 
electrodes is simulated in a volume conductor model then the field is applied to more realistic 
HH type cable models of the nerve to predict their response.
The other feature regarding this solution is the recording compartment. Various studies have 
investigated different features of surface EMG signal recorded from the external anal sphinc-
ter [63]. However, the design of the recording electrodes should be carefully carried out to 
Figure 1. (a) The device used by Knight et al. [57] and (b) the MRI of the device in situ.
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ensure the recording is selective enough, sufficient EMG amplitudes are recorded and surface 
electrodes maintain contact for chronic use. In a proof of concept study we demonstrated [64] 
a design that met the aforementioned criteria.
These led to the design of a new prototype to be tested in the subsequent clinical tests. An 
issue to bear in mind is the design of the electrode-bearing probe in terms of variability of the 
anatomy in different individuals. This should be further tested in a population of the patient 
group. Upon successful clinical trials the electronics may be embedded in the probe to have a 
fully autonomous wearable solution.
7. Conclusions
Neuromodulation is an interdisciplinary field that draws from expertise in various fields and 
is currently predominantly used for medical purposes. Neuromodulation may be applied to 
various cites of central or peripheral nervous system and the applications may range from 
treatment of mental disorders to incontinence upon SCI. Most existing neuromodulators may 
be classified as wearable as they are mostly compact, portable, may utilize connectivity and 
may have a control interface for the patient. However, if one is to exclude invasive devices 
from this category only a select group utilizing surface electrodes will qualify as wearable. 
Unfortunately, evidence shows that non-invasive neuromodulators tend to have lower effi-
cacies primarily as the neural tissue is not directly accessed. Future directions may involve 
devising design strategies that improve the efficacies of non-invasive neuromodulators or 
reducing the risks associated with invasive ones.
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